.With early phase 1 information right now out in bush, metabolic condition outfit Metsera is actuall...
.Rivus Pharmaceuticals has actually introduced the data behind its phase 2 excessive weight win in h...
.Bristol Myers Squibb is paying for Main Medication $110 million upfront to create reagents for ex l...
.Novartis has actually inked a bargain possibly worth more than $1 billion with Flagship-founded Gen...
.Lately debuted Metsera is actually unfolding some stage 1 data for its own GLP-1 receptor agonist, ...
.Amidst the genetic medications arms nationality, Main Pioneering is revealing a brand-new provider ...
.BioAge Labs is looking at about $180 million in preliminary proceeds from an IPO and also a persona...
.A try by Merck & Co. to uncover the microsatellite steady (MSS) metastatic colon cancer market h...
.Spain-based Asabys Partners has actually closed a fund of 180 thousand euros ($ 200 thousand), mone...
.BioAge Labs is actually bringing in almost $200 thousand by means of its Nasdaq IPO this morning, w...